Sudeep Pharma Board Meeting on May 21, 2026

Sudeep Pharma Ltd has scheduled a Board of Directors meeting on May 21, 2026, to consider and approve the audited standalone and consolidated financial results for the fourth quarter and year ended March 31, 2026. The board will also consider recommending a final dividend on equity shares for the financial year 2025-26. The trading window for insiders has been closed from April 1, 2026, and will remain closed until 48 hours after the declaration of the financial results, concluding on May 23, 2026.